Parkinson’s disease and nucleus basalis of Meynert integrity: Cognition and everyday function
Objective: To examine the association between the integrity of the nucleus basalis of Meynert (NBM), cognition and everyday function in Parkinson’s disease (PD). Background: Most…Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD)
Objective: To establish a large, longitudinal online cohort linked with a selected, intensively assessed cohort of people with and without PD to characterize development and…Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism
Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…Early experience using real-world monitoring to inform Parkinson’s management
Objective: To explore the utility of remote patient monitoring, using a combination of brain sensing and objective outcome measurement, in the management of Parkinson’s disease…What is the appropriate sleep position for Parkinson’s disease patients with orthostatic hypotension in the morning?
Objective: To determine the effect of sleep positions on morning OH in PD patients Background: Orthostatic hypotension (OH) is considered one of the most disabling…A systematic review of Movement Disorders in COVID-19
Objective: We conducted a systematic review to describe the frequency, clinical profile and outcomes of patients with SARS-CoV-2 associated movement disorders. Background: SARS-CoV-2 is associated…Effect of Subthalamic Nucleus Stimulation (STN-DBS) on psychosocial function using the scale “SCOPA-PS” in patients with Parkinson’s Disease at the National Institute of Neurology and Neurosurgery in Mexico during 2007 to 2020.
Objective: To determine the psychosocial function of patients with Parkinson's disease, with history of subthalamic nucleus stimulation, using the SCOPA-PS questionnaire. Background: Parkinson's disease (PD)…DNA methylation differs between idiopathic Parkinson Disease and Healthy Control subjects in the Parkinson’s Progression Marker Initiative (PPMI) cohort
Objective: Compare baseline whole blood DNA methylation in unmedicated idiopathic Parkinson's Disease (iPD) and healthy control (HC) participants from PPMI Background: Epigenetic mechanisms like DNA…Diagnostic Accuracy of Parkinson’s disease: Where Do We Stand?
Objective: To provide an up-to-date assessment of diagnostic accuracy parameters at early and late stages of the diagnosis in clinical practice and MDS Diagnostic Criteria…Reversible secondary parkinsonism attributed to metformin-induced lactic acidosis
Objective: We describe the case of a 59-year-old man who was evaluated for abnormal imaging and subacute parkinsonism. Background: Secondary parkinsonism can be caused by…
- « Previous Page
- 1
- …
- 374
- 375
- 376
- 377
- 378
- …
- 1554
- Next Page »